Outside of what we've been reporting on in terms of news and in-depth features, interviews, and in-person event coverage, behind the headlines the year also opened with a flurry of regulatory ...
Add Yahoo as a preferred source to see more of our stories on Google. -Credit:Reach Publishing Services Limited (Reach Publishing Services Limited) Jobs have been saved at a Newcastle biotech business ...
A Cambridge-based biotech specialising in human induced pluripotent stem cell (iPSC) technologies has taken on the ophthalmology business of a drug discovery partner in Newcastle. Axol Bioscience's ...
Hosted on MSN
SMG4 Remastered64: Freddy's Spaghetteria reaction!
Welcome back another FNAF reaction. Checking out SMG4's latest (to me that is lol) FNAF video and it's a complete remastered version of R64 Freddy's Spaghetteria! Enjoy :)Original Video to @SMG4 The ...
Move expands iPSC‑derived retinal model portfolio and strengthens position in research Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of ...
Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and research, today announced that it has acquired the ophthalmology business of ...
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up CAMBRIDGE, England & ...
The MarketWatch News Department was not involved in the creation of this content. -- Financing led by US life sciences investor, BroadOak Capital Partners -- Investment to support expansion of US ...
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Axol Bioscience Ltd. (Axol) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results